
Bioorganic and Medicinal Chemistry Letters p. 243 - 248 (1998)
Update date:2022-08-02
Topics:
Shih, Neng-Yang
Aslanian, Robert
Lupo Jr., Andrew T.
Orlando, Steve
Piwinski, John J.
Green, Michael J.
Ganguly, Ashit K.
West, Robert
Tozzi, Salvatore
Kreutner, William
Hey, John A.
Extensive structural modification of immepyr (+)-2 led to the dsiscovery of trans-4-methyl-3-imidazoyl pyrrolidine (±)-3a as a potent and highly selective H3 agonist. The pyrroline (±)-3a was resolved, and its (+) enantiomer, Sch 50971 [(+)-3a], showed a greater separation of H3 and H1 activities in vivo (H3/H1 ratio >> 330) than (R)-α-methylhistamine (+)-1 (H3/H1 ratio = 17), the standard H3 agonist.
View MoreContact:+86-22-83718541
Address:32th Floor, Rongqiao Center Intersection of Changjiang Road and Nankai Six Road Nankai District Tianjin 300102, China
Contact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
SHAANXI FUJIE PHARMACEUTICAL CO.,LTD
website:http://www.fujiepharm.com
Contact:+86-29-63650906
Address:Yuanqu Yi Road, Qinghe Food Industrial Park, Sanyuan County, Shaanxi Province, China
NINGBO YINLIANG FOREIGN TRADE CO., LTD.
Contact:+86-574-87834016 / 87898057
Address:23F NO.666JINYU ROAD,YINGZHOU DISTRICT,NINGBO.CHINA
Doi:10.1021/acs.joc.6b02663
(2017)Doi:10.1002/jhet.629
(2011)Doi:10.1002/jhet.5570300137
(1993)Doi:10.1135/cccc19931457
(1993)Doi:10.1016/S0031-9422(00)80770-0
(1985)Doi:10.1021/ja408238n
(2014)